Chemotherapy enhances cross-presentation of nuclear tumor antigens.

by Chidozie C Anyaegbu, Richard A Lake, Kathy Heel, Bruce W Robinson, Scott A Fisher
Published 2014-01-01

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parame...

by Alison M. McDonnell, Alistair Cook, Bruce W. S. Robinson, Richard A. Lake, Anna K. Nowak
Published 2017-06-01

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

by Esdy N. Rozali, Stanleyson V. Hato, Bruce W. Robinson, Richard A. Lake, W. Joost Lesterhuis
Published 2012-01-01

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?

by Nicola Principe, Nicola Principe, Joel Kidman, Joel Kidman, Richard A. Lake, Richard A. Lake, Willem Joost Lesterhuis, Willem Joost Lesterhuis, Anna K. Nowak, Anna K. Nowak, Alison M. McDonnell, Jonathan Chee, Jonathan Chee
Published 2021-04-01

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

by Wayne J. Aston, Danika E. Hope, Anna K. Nowak, Bruce W. Robinson, Richard A. Lake, W. Joost Lesterhuis
Published 2017-10-01

Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses

by Joel Kidman, Joel Kidman, Nicola Principe, Nicola Principe, Mark Watson, Timo Lassmann, Robert A. Holt, Anna K. Nowak, Anna K. Nowak, Willem Joost Lesterhuis, Willem Joost Lesterhuis, Willem Joost Lesterhuis, Richard A. Lake, Richard A. Lake, Jonathan Chee, Jonathan Chee
Published 2020-10-01

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

by Rachael M. Zemek, Wee Loong Chin, Wee Loong Chin, Wee Loong Chin, Anna K. Nowak, Anna K. Nowak, Anna K. Nowak, Michael J. Millward, Michael J. Millward, Richard A. Lake, Richard A. Lake, W. Joost Lesterhuis, W. Joost Lesterhuis, W. Joost Lesterhuis
Published 2020-02-01

Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model

by Scott A. Fisher, Carolyn J. Peddle-McIntyre, Kimberley Burton, Robert U.  Newton, Elly Marcq, Richard A. Lake, Anna K. Nowak
Published 2020-09-01

Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment

by Wayne J. Aston, Danika E. Hope, Alistair M. Cook, Louis Boon, Ian Dick, Anna K. Nowak, Richard A. Lake, W. Joost Lesterhuis
Published 2019-11-01

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

by Cleo Robinson, Helman Alfonso, Samantha Woo, Amy Walsh, Nola Olsen, Arthur W Musk, Bruce W S Robinson, Anna K Nowak, Richard A Lake
Published 2014-01-01

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.

by W Joost Lesterhuis, Joanne Salmons, Anna K Nowak, Esdy N Rozali, Andrea Khong, Ian M Dick, Julie A Harken, Bruce W Robinson, Richard A Lake
Published 2013-01-01

How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers

by Kiarash Behrouzfar, Kiarash Behrouzfar, Kimberley Burton, Kimberley Burton, Steve E. Mutsaers, Steve E. Mutsaers, Grant Morahan, Richard A. Lake, Scott A. Fisher, Scott A. Fisher
Published 2021-06-01

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

by Jonathan Chee, Mark W. Watson, Abha Chopra, Bella Nguyen, Alistair M. Cook, Jenette Creaney, Willem J. Lesterhuis, Bruce W. Robinson, Y. C. Gary Lee, Anna K. Nowak, Richard A. Lake, Alison M. McDonnell
Published 2018-12-01

Combination immune checkpoint blockade as an effective therapy for mesothelioma

by Vanessa S. Fear, Caitlin Tilsed, Jonathan Chee, Catherine A. Forbes, Thomas Casey, Jessica N. Solin, Sally M. Lansley, Willem Joost Lesterhuis, Ian M. Dick, Anna K Nowak, Bruce W. Robinson, Richard A. Lake, Scott A. Fisher
Published 2018-10-01

Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.

by Robbert G van der Most, Andrew J Currie, Amanda L Cleaver, Joanne Salmons, Anna K Nowak, Sathish Mahendran, Irma Larma, Amy Prosser, Bruce W S Robinson, Mark J Smyth, Anthony A Scalzo, Mariapia A Degli-Esposti, Richard A Lake
Published 2009-09-01

Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy

by Nicola Principe, Nicola Principe, Joel Kidman, Joel Kidman, Siting Goh, Caitlin M. Tilsed, Caitlin M. Tilsed, Scott A. Fisher, Scott A. Fisher, Vanessa S. Fear, Catherine A. Forbes, Rachael M. Zemek, Abha Chopra, Mark Watson, Ian M. Dick, Ian M. Dick, Louis Boon, Robert A. Holt, Richard A. Lake, Richard A. Lake, Anna K. Nowak, Anna K. Nowak, Willem Joost Lesterhuis, Willem Joost Lesterhuis, Willem Joost Lesterhuis, Alison M. McDonnell, Alison M. McDonnell, Alison M. McDonnell, Jonathan Chee, Jonathan Chee
Published 2020-11-01